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Respiratory complex III (CIII) is the central complex of the respiratory
chain. In its native form, CIII is dimeric, and is closely associated in varying
proportions with CI and CIV to form supramolecular structures, called
supercomplexes [1]. The occurrence of such supercomplexes as structural
and functional entities has been recently documented [1,2]. However, the
physiological implications of such speciﬁc supramolecular interactions
are not yet fully understood. Mutations in cytochrome b, which is the
only CIII subunit encoded by the mitochondrial genome, are among
the least common abnormalities identiﬁed to date in humans [3].
Recent studies on the bacterial enzyme proposed that speciﬁc amino
acids at the Qo site of CIII might provide protective mechanisms
against oxidative damage. Interestingly, the conserved Tyr residue at
position 302 of Rhodobacter capsulatus cytochrome b is critical for this
process [4]. The same mutation at position 278 of human cytochrome
b (p.Y278C, m.15579ANG) has also been encountered in a patient
with severe exercise intolerance and multisystem disorder [5]. Here
we have utilized cybrids bearing the homoplasmic p.Y278C mutation
to dissect the biochemical alterations in CIII activity, ROS production
and supercomplexes assembly/stability. Despite a dramatic reduction
in CIII activity, and in CIII-driven ATP synthesis, the CI and I+III
activities were less affected, and the rate of ATP synthesis driven by CI
or CII substrates was only partially reduced. Accordingly, mutated
cybrids maintained the mitochondrial potential in the presence of
oligomycin. Remarkably, the p.Y278C mutation enhanced superoxide
production and perturbed glutathione homeostasis. Finally, exami-
nation of respiratory supercomplexes revealed that dimeric CIII and
III2IV1 were markedly decreased, whereas supercomplexes I1III2IVn
increased. These ﬁndings suggest that the deleterious effects of
cytochrome b p.Y278C mutation are mitigated when CIII is assembled
into the supercomplexes I1III2IVn and underline the importance of
supramolecular interactions between respiratory complexes on dis-
ease manifestations associated with this mutation.
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Both respiratory and photosynthetic electron transport are crucial
for energy conversion in plants and many microbes. In cyanobacteria,
respiratory electron transport takes place in close proximity to pho-
tosynthetic electron transport, because the complexes required for both
processes are locatedwithin the thylakoidmembranes [1,2]. This allows
“unorthodox” electron transport pathways in which electrons cross
over from respiratory donors to photosynthetic acceptors, or vice versa
[3]. The balance of electron transport routes is crucial for cell physiology
[4], yet the factors that control the predominance of particular path-
ways are poorly understood. Herewe use a combination of taggingwith
green ﬂuorescent protein and confocal ﬂuorescence microscopy in live
cells of the cyanobacterium Synechococcus elongatus PCC 7942 to
investigate the distribution on submicron scales of two key respira-
tory electron donors, type-I NAD(P)H dehydrogenase (NDH-1) and
succinate dehydrogenase (SDH) [5]. When cells are grown under low
light, both complexes are concentrated in discrete patches in the
thylakoid membranes, about 100–300 nm in diameter and containing
tens to hundreds of complexes. Exposure to moderate light leads to
redistribution of both NDH-1 and SDH such that they become evenly
distributed within the thylakoid membranes. The effects of electron
transport inhibitors indicate that redistribution of respiratory com-
plexes is triggered by changes in the redox state of an electron carrier
close to plastoquinone. Redistribution does not depend on de novo
protein synthesis, and it is accompanied by a major increase in the
probability that respiratory electrons are transferred to photosystem I
rather than to a terminal oxidase. These results indicate that the
distribution of complexes on the scale of 100–300 nm controls the
partitioning of reducing power and that redistribution of electron
transport complexes on these scales is a physiological mechanism to
regulate the pathways of electron ﬂow.
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Mitochondrial complex III deﬁciency is a relatively infrequent
disorder that underlies a wide range of neuromuscular and multi-
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systemic disorders of variable severity. Due to the complex III dual
genetic origin, these enzyme defects can be attributed to mutations
located either in mitochondrial or in nuclear genes. An increasing
number of speciﬁc regulatory proteins involved in the biosynthesis
of this respiratory chain complex that may also lead to complex III
deﬁciency has been described. One of these proteins is BCS1L, an
assembly factor that facilitates the insertion of the catalytic Rieske
Iron–Sulfur subunit into respiratory chain complex III. Mutations in
the BCS1L gene constitue the main cause of complex III deﬁciency. In
the search for potential biomarkers for complex III deﬁciency we
performed two-dimensional difference gel electrophoresis (2D DIGE)
followed by spot picking and subsequent protein digestion for mass
spectrometry (MS) identiﬁcation in ﬁbroblasts from four complex III-
deﬁcient patients harboring mutations in the BCS1L gene and four
independent controls. Here we report 41 proteins that are differen-
tially expressed in patients harbouring BCS1L mutations compared to
controls. These proteins are mainly related to energy metabolism,
cytoskeleton maintenance processes, regulation of DNA transcription
and replication and protein synthesis, cell cycle regulation and oxidative
stress response. Further studies are required for the validation and
functional characterization of possible biomarkers that may be of im-
portance for future diagnostic, therapeutic, and prognostic approaches in
mitochondrial disorders.
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The mitochondrial phosphorylation apparatus consists of three
protein components — ADP/ATP carrier (AAC), inorganic phosphate
carrier (PiC), and F1Fo-ATP synthase. According to some experimen-
tal evidence, these proteins of the inner mitochondrial membrane
could interact not only functionally, but also structurally [1]. Their
supercomplex called ATP synthasome would show better catalytic
efﬁciency of ATP synthesis.
To characterize interactions of AAC, PiC, and ATP synthase in
mammalian cells, we used two models of isolated ATP synthase
deﬁciency — rat brown adipose tissue with physiological deﬁciency of
ATP synthase due to low expression of Fo-c subunit and ﬁbroblast
cultures of patients with ATP synthase deﬁciency caused by a mutation
in the assembly factor TMEM70. SDS-PAGE/WB analysis of isolated
mitochondria revealed that among rat tissues, AAC and PiC are most
abundant in the tissues with high energetic demands, i.e. in heart and
skeletalmuscle. However, their amountwas also high in brown adipose
tissue despite the low content of ATP synthase. In the ATP synthase
deﬁcient patients' ﬁbroblasts, we also found a high content of AAC and
PiC that was even increased in comparison to control cells. The lack of
correlation in the contents of ATP synthase and mitochondrial carriers
AAC and PiC does not support a direct relationship in the regulation of
their biogenesis.
Simultaneously, we studied structural interactions of AAC, PiC,
and ATP synthase using various approaches. Detergent-solubilized
mitochondria were used for immunoprecipitation and native
and two-dimensional gel electrophoreses combined with either
immunodetection with speciﬁc antibodies or MS analysis. Our results
indicate that both carriers interact with monomeric and oligomeric
forms of ATP synthase. The majority of these carriers, however, are
present out of ATP synthasome, probably as dimers.
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The biogenesis and function of themitochondrial respiratory chain
(RC) involves the association of individual RC enzyme complexes into
supercomplexes or respirasomes, through a biosynthetic process
that remains largely unknown. Here we show that in human cells,
I+III2+IVn supercomplexes do not originate from the association
of fully-assembled individual holoenzymes. Rather, we demonstrate
that respirasome biogenesis involves a complex I assembly interme-
diate acting as a scaffold for the combined incorporation of free
subunits and subcomplexes from complexes III and IV. The process
ends with the association of the complex I NADH dehydrogenase
catalytic module, which leads to complex I and respirasome activa-
tion. Our studies reveal that while complexes III and IV can assemble
either as free holoenzymes or by incorporation of free subunits into
supercomplexes, the respirasomes constitute the structural units
where complex I is assembled and activated, thus explaining the
signiﬁcance of the respirasomes for RC function.
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The Translocase of the Outer mitochondrial Membrane (TOM) is a
protein complex that translocates nuclear encoded proteins into
mitochondria. The isolated TOM holo complex consists of the pore-
forming channel protein Tom40, Tom22 and the small Tom proteins
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